CYTEK BIOSCIENCES, INC. Interest Expense Nonoperating
CYTEK BIOSCIENCES, INC. (CTKB) reported Interest Expense Nonoperating of $281.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Expense Statement
us-gaap:InterestExpenseNonoperating · last filed 2026-08-05
- CYTEK BIOSCIENCES, INC. interest expense nonoperating for the quarter ending 2026-06-30 was $281.00K, a 32.13% decline year-over-year.
- CYTEK BIOSCIENCES, INC. interest expense nonoperating for the quarter ending 2026-03-31 was $262.00K, a 9.97% decline year-over-year.
- CYTEK BIOSCIENCES, INC. interest expense nonoperating for the quarter ending 2025-12-31 was -$725.00K.
- CYTEK BIOSCIENCES, INC. interest expense nonoperating for the quarter ending 2025-09-30 was $494.00K, a 315.13% increase year-over-year.
- CYTEK BIOSCIENCES, INC. interest expense nonoperating for fiscal 2025 was $474.00K.
- CYTEK BIOSCIENCES, INC. interest expense nonoperating for fiscal 2024 was -$5.24M, a 352.97% decline from fiscal 2023.
- CYTEK BIOSCIENCES, INC. interest expense nonoperating for fiscal 2023 was $2.07M, a 19.51% decline from fiscal 2022.
- CYTEK BIOSCIENCES, INC. interest expense nonoperating for fiscal 2022 was $2.57M.
| Period end | Interest Expense Nonoperating 3 month | Interest Expense Nonoperating 6 month | Interest Expense Nonoperating 9 month | Interest Expense Nonoperating 12 month |
|---|---|---|---|---|
| 2026-06-30 | $281.00K 10-Q · filed 2026-08-05 | $543.00K 10-Q · filed 2026-08-05 | -$182.00K derived: sum of 3 quarters · filed 2026-08-05 | $312.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $262.00K 10-Q · filed 2026-05-07 | -$463.00K derived: sum of 2 quarters · filed 2026-05-07 | $31.00K derived: sum of 3 quarters · filed 2026-05-07 | $445.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | -$725.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$231.00K derived: sum of 2 quarters · filed 2026-02-26 | $183.00K derived: sum of 3 quarters · filed 2026-08-05 | $474.00K 10-K · filed 2026-02-26 |
| 2025-09-30 | $494.00K 10-Q · filed 2025-11-05 | $908.00K derived: sum of 2 quarters · filed 2026-08-05 | $1.20M 10-Q · filed 2025-11-05 | -$4.73M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $414.00K 10-Q · filed 2026-08-05 | $705.00K 10-Q · filed 2026-08-05 | -$5.23M derived: sum of 3 quarters · filed 2026-08-05 | -$5.11M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $291.00K 10-Q · filed 2026-05-07 | -$5.64M derived: sum of 2 quarters · filed 2026-05-07 | -$5.52M derived: sum of 3 quarters · filed 2026-05-07 | -$5.39M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | -$5.93M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$5.81M derived: sum of 2 quarters · filed 2026-02-26 | -$5.68M derived: sum of 3 quarters · filed 2026-02-26 | -$5.24M 10-K · filed 2026-02-26 |
| 2024-09-30 | $119.00K 10-Q · filed 2025-11-05 | $253.00K derived: sum of 2 quarters · filed 2025-11-05 | $694.00K 10-Q · filed 2025-11-05 | $1.09M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $134.00K 10-Q · filed 2025-08-06 | $575.00K 10-Q · filed 2025-08-06 | $969.00K derived: sum of 3 quarters · filed 2026-02-26 | $1.56M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $441.00K 10-Q · filed 2025-05-08 | $835.00K derived: sum of 2 quarters · filed 2026-02-26 | $1.43M derived: sum of 3 quarters · filed 2026-02-26 | $1.84M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $394.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $989.00K derived: sum of 2 quarters · filed 2026-02-26 | $1.40M derived: sum of 3 quarters · filed 2026-02-26 | $2.07M 10-K · filed 2026-02-26 |
| 2023-09-30 | $595.00K 10-Q · filed 2024-11-07 | $1.00M derived: sum of 2 quarters · filed 2024-11-07 | $1.68M 10-Q · filed 2024-11-07 | |
| 2023-06-30 | $409.00K 10-Q · filed 2024-08-06 | $1.08M 10-Q · filed 2024-08-06 | ||
| 2022-12-31 | $2.57M 10-K · filed 2025-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B |